Monitor for a subsequent prospectus supplement or ATM takedown, which would specify actual offering size and trigger dilution. Given the company's early-stage status, any future raise is likely to be dilutive; watch for pricing and share count details in follow-up filings.
Price Chart
Executive Summary
Intelligent Bio Solutions Inc. filed a Form S-3 shelf registration statement, signaling potential future issuance of common stock, preferred stock, warrants, and units. The filing does not specify an offering size or share count, and the stated use of proceeds is general corporate purposes, including working capital and potential acquisitions. This is a routine shelf registration that enables future capital raises but does not itself constitute an offering.
Key Facts
- Form S-3 shelf registration filed, covering common stock, preferred stock, warrants, and units
- No offering size or share count specified in the filing
- Proceeds to be used for general corporate purposes, including working capital and potential acquisitions
- Company is a pre-revenue or early-stage biotech with minimal operating revenue
- No specific dilution percentage calculable from the filing
Financial Impact
Undisclosed amount; no offering size or share count provided in the filing
Risk Factors
- Future share issuance could dilute existing shareholders
- Company may need capital to fund operations, given early-stage revenue profile
- Shelf registration enables rapid capital raises without prior notice
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001493152-26-042775 |
| Exhibit: ex107.htm | 0001493152-26-042775 |
| Exhibit: ex5-1.htm | 0001493152-26-042775 |
| Exhibit: ex23-1.htm | 0001493152-26-042775 |
| Document: 0001493152-26-042775-index-headers.html | 0001493152-26-042775 |
| Document: 0001493152-26-042775-index.html | 0001493152-26-042775 |
| Document: 0001493152-26-042775.txt | 0001493152-26-042775 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 10-K/A | $1.69 | awaiting T+20 | — | $1.65 (−2.08%) |
Oct 13, 2026 13d ago | 8-K | $1.45 | awaiting T+20 | — | $1.65 (+13.79%) |
Sep 24, 2026 4w ago | EFFECT | $1.71 $1.69 | ▲ +1.46% | ▲ +1.04% | $1.65 (+3.51%) |
Sep 15, 2026 5w ago | S-3 | $1.97 $1.48 | ▼ −24.87% | ▼ −28.05% | $1.65 (−16.24%) |
Sep 11, 2026 6w ago | 8-K | $2.07 $1.51 | ▼ −27.05% | ▼ −29.32% | $1.65 (−20.29%) |
Sep 9, 2026 6w ago | 8-K | $2.24 $1.59 | ▼ −29.02% | ▼ −30.96% | $1.65 (−26.34%) |
Sep 2, 2026 7w ago | 8-K | $2.30 $1.66 | ▲ +27.83% | ▲ +26.64% | $1.65 (+28.26%) |
Aug 19, 2026 9w ago | 8-K | $2.67 $2.05 | ▼ −23.22% | ▼ −21.70% | $1.65 (−38.20%) |
Aug 19, 2026 9w ago | Press Release | $2.67 $2.05 | ▲ +23.22% | ▲ +21.70% | $1.65 (+38.20%) |
Aug 17, 2026 10w ago | Press Release | $3.37 $2.05 | ▼ −39.17% | ▼ −37.19% | $1.65 (−51.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers